160 related articles for article (PubMed ID: 11201885)
1. Chemoprophylaxis against leprosy: expectations and methodology of a trial.
Vijayakumaran P; Krishnamurthy P; Rao P; Declerq E
Lepr Rev; 2000 Dec; 71 Suppl():S37-40; discussion S40-1. PubMed ID: 11201885
[TBL] [Abstract][Full Text] [Related]
2. Role of contact tracing and prevention strategies in the interruption of leprosy transmission.
Smith WC; Aerts A
Lepr Rev; 2014 Mar; 85(1):2-17. PubMed ID: 24974438
[TBL] [Abstract][Full Text] [Related]
3. The combined effect of chemoprophylaxis with single dose rifampicin and immunoprophylaxis with BCG to prevent leprosy in contacts of newly diagnosed leprosy cases: a cluster randomized controlled trial (MALTALEP study).
Richardus RA; Alam K; Pahan D; Feenstra SG; Geluk A; Richardus JH
BMC Infect Dis; 2013 Oct; 13():456. PubMed ID: 24088534
[TBL] [Abstract][Full Text] [Related]
4. Patient-related factors predicting the effectiveness of rifampicin chemoprophylaxis in contacts: 6 year follow up of the COLEP cohort in Bangladesh.
Feenstra SG; Pahan D; Moet FJ; Oskam L; Richardus JH
Lepr Rev; 2012 Sep; 83(3):292-304. PubMed ID: 23356030
[TBL] [Abstract][Full Text] [Related]
5. Post-exposure prophylaxis in leprosy (PEOPLE): a cluster randomised trial.
Hasker E; Assoumani Y; Randrianantoandro A; Ramboarina S; Braet SM; Cauchoix B; Baco A; Mzembaba A; Salim Z; Amidy M; Grillone S; Attoumani N; Grillone SH; Ronse M; Peeters Grietens K; Rakoto-Andrianarivelo M; Harinjatovo H; Supply P; Snijders R; Hoof C; Tsoumanis A; Suffys P; Rasamoelina T; Corstjens P; Ortuno-Gutierrez N; Geluk A; Cambau E; de Jong BC
Lancet Glob Health; 2024 Jun; 12(6):e1017-e1026. PubMed ID: 38762282
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of a chemoprophylactic intervention with single dose rifampicin in contacts of new leprosy patients.
Idema WJ; Majer IM; Pahan D; Oskam L; Polinder S; Richardus JH
PLoS Negl Trop Dis; 2010 Nov; 4(11):e874. PubMed ID: 21072235
[TBL] [Abstract][Full Text] [Related]
7. A study on transmission and a trial of chemoprophylaxis in contacts of leprosy patients: design, methodology and recruitment findings of COLEP.
Moet FJ; Oskam L; Faber R; Pahan D; Richardus JH
Lepr Rev; 2004 Dec; 75(4):376-88. PubMed ID: 15682975
[TBL] [Abstract][Full Text] [Related]
8. Chemoprophylaxis of leprosy in the southern Marquesas with a single 25 mg/kg dose of rifampicin. Results after 10 years.
Nguyen LN; Cartel JL; Grosset JH
Lepr Rev; 2000 Dec; 71 Suppl():S33-5; discussion S35-6. PubMed ID: 11201884
[TBL] [Abstract][Full Text] [Related]
9. Comparison of PCR mediated amplification of DNA and the classical methods for detection of Mycobacterium leprae in different types of clinical samples in leprosy patients and contacts.
Torres P; Camarena JJ; Gomez JR; Nogueira JM; Gimeno V; Navarro JC; Olmos A
Lepr Rev; 2003 Mar; 74(1):18-30. PubMed ID: 12669929
[TBL] [Abstract][Full Text] [Related]
10. Protecting people against leprosy: chemoprophylaxis and immunoprophylaxis.
Richardus JH; Oskam L
Clin Dermatol; 2015; 33(1):19-25. PubMed ID: 25432807
[TBL] [Abstract][Full Text] [Related]
11. Serological response to chemoprophylaxis in extended contacts in leprosy--a randomized controlled trial.
Oo KN; Yin NN; Han TT; Wai KT; Myint K; Gyi MM
Nihon Hansenbyo Gakkai Zasshi; 2008 Feb; 77(1):3-10. PubMed ID: 18341017
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of single dose rifampicin in preventing leprosy in close contacts of patients with newly diagnosed leprosy: cluster randomised controlled trial.
Moet FJ; Pahan D; Oskam L; Richardus JH;
BMJ; 2008 Apr; 336(7647):761-4. PubMed ID: 18332051
[TBL] [Abstract][Full Text] [Related]
13. Treatment of leprosy.
Kar HK; Gupta R
Clin Dermatol; 2015; 33(1):55-65. PubMed ID: 25432811
[TBL] [Abstract][Full Text] [Related]
14. Multidrug therapy (MDT) and leprosy control.
Noordeen SK
Indian J Lepr; 1990; 62(4):448-58. PubMed ID: 2086680
[No Abstract] [Full Text] [Related]
15. Response to treatment by multidrug regimens in the THELEP controlled clinical drug trials. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP) Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.
Lepr Rev; 1996 Dec; 67(4):260-79. PubMed ID: 9033197
[TBL] [Abstract][Full Text] [Related]
16. Leprosy now: epidemiology, progress, challenges, and research gaps.
Rodrigues LC; Lockwood DNj
Lancet Infect Dis; 2011 Jun; 11(6):464-70. PubMed ID: 21616456
[TBL] [Abstract][Full Text] [Related]
17. Clinical manifestations of leprosy after BCG vaccination: an observational study in Bangladesh.
Richardus RA; Butlin CR; Alam K; Kundu K; Geluk A; Richardus JH
Vaccine; 2015 Mar; 33(13):1562-7. PubMed ID: 25701674
[TBL] [Abstract][Full Text] [Related]
18. Prophylaxis--scope and limitations.
Noordeen SK
Lepr Rev; 2000 Dec; 71 Suppl():S16-9; discussion S19-20. PubMed ID: 11201874
[TBL] [Abstract][Full Text] [Related]
19. Impact of MDT on incidence rates of leprosy among household contacts. Part 1. Baseline data.
Sundar Rao PS; Jesudasan K; Mani K; Christian M
Int J Lepr Other Mycobact Dis; 1989 Sep; 57(3):647-51. PubMed ID: 2778370
[TBL] [Abstract][Full Text] [Related]
20. Drug resistance patterns in Mycobacterium leprae isolates from relapsed leprosy patients attending The Leprosy Mission (TLM) Hospitals in India.
Lavania M; Jadhav RS; Chaitanya VS; Turankar R; Selvasekhar A; Das L; Darlong F; Hambroom UK; Kumar S; Sengupta U
Lepr Rev; 2014 Sep; 85(3):177-85. PubMed ID: 25509718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
